 |
Page History
...
| Data Element | Description | ||||||
|---|---|---|---|---|---|---|---|
| NCI ID | The
| ||||||
| Lead Org ID | The
| ||||||
| Title | The
| ||||||
| Lead Organization PO ID | The unique ID assigned to the lead organization by the CTRP. For information, refer to Abstracting Trial Descriptions, Titles, and Identifiers. | ||||||
| Lead Organization | The
| ||||||
| NCT ID | The
| ||||||
| CTEP ID | The
| ||||||
| DCP ID | The
| ||||||
| Funding Mechanism | A
| ||||||
| NCI Division/Program | The NCI division or program identified in an IND, IDE, or grant record, as the
| ||||||
| Institution Code (NIH Grant Institute Code) | The NIH institute institution associated with the trial, as identified in an IND, IDE, or IDE record. It is a Trial Attribute Institute Code - Include v4.4 | Trial Attribute Institute Code - Include v4.4 | For information, refer to grant record. For information, refer to NIH Institution Code Values, NIH Grant Institute Code Values or , Abstracting INDs and IDEs, or Abstracting Funding. | ||||
| IND/IDE Grantor | The
For information, refer to Abstracting INDs and IDEs. | ||||||
| IND/IDE Holder Type | The
For information, refer to Abstracting INDs and IDEs. | ||||||
| IND/IDE Number | The
| ||||||
| IND/IDE Types | A value indicating
| ||||||
| Section 801 Indicator | A value indicating
| ||||||
| Principal Investigator | The
| ||||||
| Sponsor Org | The
| ||||||
| Responsible Party | The
| ||||||
| Summary 4 Funding Sponsor | The
| ||||||
| Trial Status | The
| ||||||
| Trial Status Date | The
| ||||||
| Trial Start Date | The
| ||||||
| Primary Completion Date | The
| ||||||
| Primary Completion Date Type | A
| ||||||
| Submitting Org Name | The name of the organization that submitted the trial. | ||||||
| Current Processing Status | The
| ||||||
| Study Category | The
| ||||||
| Submission Number | A
| ||||||
| Trial Submission Type | A value indicating
| ||||||
| Trial Summary Report Sent Date | The date on which the system sent the Trial Summary Report (TSR) to the principal investigator or trial submitter. For information, refer to Processing Trial Milestones. |
